Your session is about to expire
← Back to Search
Voxelotor Only Product in Oral Dose Form for Sickle Cell Disease
Study Summary
This trial will test if voxelotor can improve neurocognitive function in children with sickle cell disease.
- Sickle Cell Disease
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are the patients in this trial required to be of age?
"This research project is only enrolling participants that are children aged 8-17. Out of the over 200 clinical trials currently underway, 133 involve minors and 86 involve patients over 65 years old."
Is Voxelotor the only FDA-approved oral medication?
"This medication, which is taken orally in the form of a pill, received a safety rating of 3. This reflects that there have been multiple rounds of testing supporting Voxelotor's safety as well as some evidence of efficacy."
To whom does this clinical trial grant admission?
"This particular medical trial is testing a new intervention for patients with anemia and sickle cell that are between the ages of 8 and 17. They are looking to enroll around 80 children in total."
Share this study with friends
Copy Link
Messenger